Cost‐effectiveness of rapid hepatitis<scp>C</scp>virus (<scp>HCV</scp>) testing and simultaneous rapid<scp>HCV</scp>and<scp>HIV</scp>testing in substance abuse treatment programs - Concepedia

Concepedia

Publication | Open Access

Cost‐effectiveness of rapid hepatitis<scp>C</scp>virus (<scp>HCV</scp>) testing and simultaneous rapid<scp>HCV</scp>and<scp>HIV</scp>testing in substance abuse treatment programs

DOI Full Paper Access

52

Citations

91

References

2014

Year

Bruce R. Schackman, Jared A. Leff, Devra M. Barter, Madeline A. DiLorenzo, Daniel J. Feaster, Lisa R. Metsch, Kenneth A. Freedberg, Benjamin P. Linas

Abstract

On-site rapid hepatitis C virus and HIV testing in substance abuse treatment programs is cost-effective at a <$100,000/quality-adjusted life year threshold.

References

	Year	Citations

Page 1